{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:54:09Z","timestamp":1780541649119,"version":"3.54.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Mild to moderate hypertriglyceridemia is a condition often associated with obesity and diabetes, with as yet incomplete knowledge of underlying genetic architecture. The 22q11.2 microdeletion is associated with multimorbidity, including increased risk of obesity and diabetes. In this study, we sought to investigate whether the 22q11.2 microdeletion was associated with mild to moderate hypertriglyceridemia (1.7\u201310 mmol\/L).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>This was a cohort study comparing 6793 population-based adults and 267 with a 22q11.2 microdeletion aged 17\u201369 years, excluding those with diabetes or on statins.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used binomial logistic regression modeling to identify predictors of hypertriglyceridemia, accounting for the 22q11.2 microdeletion, male sex, BMI, ethnicity, age, and antipsychotic medications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The 22q11.2 microdeletion was a significant independent predictor of mild to moderate hypertriglyceridemia (odds ratio (OR): 2.35, 95% CI: 1.70\u20133.26). All other factors examined were also significant predictors (OR: 1.23\u20132.10), except for antipsychotic medication use. Within the 22q11.2 microdeletion subgroup, only male sex (OR: 3.10, 95% CI: 1.77\u20135.44) and BMI (OR: 1.63, 95% CI: 1.14\u20131.98) were significant predictors of hypertriglyceridemia, evident at mean age 31.2 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The 22q11.2 microdeletion is associated with hypertriglyceridemia even when accounting for other known risk factors for elevated triglycerides. This effect is seen in young adulthood (76.6% were &amp;lt;40 years), in the absence of diabetes, and irrespective of antipsychotics, suggesting that the 22q11.2 microdeletion may represent an unrecognized genetic risk factor for hypertriglyceridemia, providing novel opportunities for animal and cellular models. Early dyslipidemia screening and management strategies would appear prudent for individuals with 22q11.2 microdeletions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1530\/eje-21-1104","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T10:06:36Z","timestamp":1651831596000},"page":"91-99","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-7","source":"Crossref","is-referenced-by-count":16,"title":["Hypertriglyceridemia in young adults with a 22q11.2 microdeletion"],"prefix":"10.1093","volume":"187","author":[{"given":"Christina","family":"Blagojevic","sequence":"first","affiliation":[{"name":"Clinical Genetics Research Program, Centre for Addiction and Mental Health , Toronto, Ontario, Canada"},{"name":"The Dalglish Family 22q Clinic, University Health Network , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Heung","sequence":"additional","affiliation":[{"name":"Clinical Genetics Research Program, Centre for Addiction and Mental Health , Toronto, Ontario, Canada"},{"name":"The Dalglish Family 22q Clinic, University Health Network , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Malecki","sequence":"additional","affiliation":[{"name":"Clinical Genetics Research Program, Centre for Addiction and Mental Health , Toronto, Ontario, Canada"},{"name":"The Dalglish Family 22q Clinic, University Health Network , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Ying","sequence":"additional","affiliation":[{"name":"Clinical Genetics Research Program, Centre for Addiction and Mental Health , Toronto, Ontario, Canada"},{"name":"The Dalglish Family 22q Clinic, University Health Network , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Cancelliere","sequence":"additional","affiliation":[{"name":"Clinical Genetics Research Program, Centre for Addiction and Mental Health , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-5325","authenticated-orcid":false,"given":"Robert A","family":"Hegele","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Biochemistry, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University , London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0681-7279","authenticated-orcid":false,"given":"Anne S","family":"Bassett","sequence":"additional","affiliation":[{"name":"Clinical Genetics Research Program, Centre for Addiction and Mental Health , Toronto, Ontario, Canada"},{"name":"The Dalglish Family 22q Clinic, University Health Network , Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto General Hospital Research Institute, and Campbell Family Mental Health Research Institute , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"2023010809165544000_bib1","first-page":"689","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nature Reviews: Cardiology"},{"key":"2023010809165544000_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/HCO.0000000000000839","article-title":"Genetics of hypertriglyceridemia and atherosclerosis","volume":"36","author":"Gill","year":"2021","journal-title":"Current Opinion in Cardiology"},{"key":"2023010809165544000_bib3","doi-asserted-by":"crossref","first-page":"100528","DOI":"10.1016\/j.eclinm.2020.100528","article-title":"22q11.2 microdeletion and increased risk for type 2 diabetes","volume":"26","author":"Van","year":"2020","journal-title":"EClinicalmedicine"},{"key":"2023010809165544000_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jmedgenet-2018-105477","article-title":"Medical consequences of pathogenic CNVs in adults: analysis of the UK Biobank","volume":"56","author":"Crawford","year":"2019","journal-title":"Journal of Medical Genetics"},{"key":"2023010809165544000_bib5","doi-asserted-by":"crossref","first-page":"E802","DOI":"10.9778\/cmajo.20200294","article-title":"Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening","volume":"9","author":"Blagojevic","year":"2021","journal-title":"CMAJ Open"},{"key":"2023010809165544000_bib6","first-page":"15071","article-title":"22q11.2 deletion syndrome","volume":"1","author":"McDonald-McGinn","year":"2015","journal-title":"Nature Reviews: Disease Primers"},{"key":"2023010809165544000_bib7","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ajmg.a.38645","article-title":"Elucidating the diagnostic odyssey of 22q11.2 deletion syndrome","volume":"176","author":"Palmer","year":"2018","journal-title":"American Journal of Medical Genetics: Part A"},{"key":"2023010809165544000_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41436-019-0603-1","article-title":"A genetic model for multimorbidity in young adults","volume":"22","author":"Malecki","year":"2020","journal-title":"Genetics in Medicine"},{"key":"2023010809165544000_bib9","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/s41436-019-0509-y","article-title":"All-cause mortality and survival in adults with 22q11.2 deletion syndrome","volume":"21","author":"Van","year":"2019","journal-title":"Genetics in Medicine"},{"key":"2023010809165544000_bib10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"2023010809165544000_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/gim.2016.98","article-title":"Obesity in adults with 22q11.2 deletion syndrome","volume":"19","author":"Voll","year":"2017","journal-title":"Genetics in Medicine"},{"key":"2023010809165544000_bib12","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"2023010809165544000_bib13","first-page":"880","article-title":"Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice","volume":"7","author":"Garg","year":"2019","journal-title":"Lancet: Diabetes and Endocrinology"},{"key":"2023010809165544000_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1194\/jlr.R009720","article-title":"Genetic determinants of plasma triglycerides","volume":"52","author":"Johansen","year":"2011","journal-title":"Journal of Lipid Research"},{"issue":"Supplement 1","key":"2023010809165544000_bib15","first-page":"S10","article-title":"Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome","volume":"42","author":"Diabetes Canada Clinical Practice Guidelines Expert Committee","year":"2018","journal-title":"Canadian Journal of Diabetes"},{"key":"2023010809165544000_bib16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","article-title":"2021 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Canadian Journal of Cardiology"},{"key":"2023010809165544000_bib17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cjca.2016.07.510","article-title":"2016 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Canadian Journal of Cardiology"},{"key":"2023010809165544000_bib18","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.108.804146","article-title":"Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction","volume":"118","author":"Langsted","year":"2008","journal-title":"Circulation"},{"key":"2023010809165544000_bib19","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archinternmed.2012.3708","article-title":"Fasting time and lipid levels in a community-based population: a cross-sectional study","volume":"172","author":"Sidhu","year":"2012","journal-title":"Archives of Internal Medicine"},{"key":"2023010809165544000_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-8981(99)00098-4","article-title":"HDL metabolism in hypertriglyceridemic states: an overview","volume":"286","author":"Lamarche","year":"1999","journal-title":"Clinica Chimica Acta: International Journal of Clinical Chemistry"},{"key":"2023010809165544000_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmet.2018.05.008","article-title":"Sex differences in lipid and lipoprotein metabolism","volume":"15","author":"Palmisano","year":"2018","journal-title":"Molecular Metabolism"},{"key":"2023010809165544000_bib22","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1038\/s41380-020-0654-3","article-title":"Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion","volume":"26","author":"Cleynen","year":"2021","journal-title":"Molecular Psychiatry"},{"key":"2023010809165544000_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MOL.0000000000000581","article-title":"Progress in finding pathogenic DNA copy number variations in dyslipidemia","volume":"30","author":"Iacocca","year":"2019","journal-title":"Current Opinion in Lipidology"},{"key":"2023010809165544000_bib24","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nature Genetics"},{"key":"2023010809165544000_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"2023010809165544000_bib26","doi-asserted-by":"crossref","first-page":"28.e2","DOI":"10.1016\/j.jacl.2020.01.003","article-title":"The polygenic nature of mild-to-moderate hypertriglyceridemia","volume":"14","author":"Dron","year":"2020","journal-title":"Journal of Clinical Lipidology"},{"key":"2023010809165544000_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2018.10.006","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"Journal of Clinical Lipidology"},{"key":"2023010809165544000_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/oby.22370","article-title":"Trends in lipids, obesity, metabolic syndrome, and diabetes mellitus in the United States: an NHANES analysis (2003\u20132004 to 2013\u20132014)","volume":"27","author":"Palmer","year":"2019","journal-title":"Obesity"},{"key":"2023010809165544000_bib29","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/aje\/kwi103","article-title":"Relative contributions of genes, environment, and interactions to blood lipid concentrations in a general adult population","volume":"161","author":"Costanza","year":"2005","journal-title":"American Journal of Epidemiology"},{"key":"2023010809165544000_bib30","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1373\/clinchem.2004.032763","article-title":"Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham study","volume":"50","author":"Freedman","year":"2004","journal-title":"Clinical Chemistry"},{"key":"2023010809165544000_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12944-021-01517-6","article-title":"Incidence, predictors and patterns of care of patients with very severe hypertriglyceridemia in Ontario, Canada: a population-based cohort study","volume":"20","author":"Berberich","year":"2021","journal-title":"Lipids in Health and Disease"},{"key":"2023010809165544000_bib32","first-page":"47","article-title":"Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver","volume":"17","author":"Goossens","year":"2021","journal-title":"Nature Reviews: Endocrinology"},{"key":"2023010809165544000_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jacl.2018.11.008","article-title":"Hypertriglyceridemia in statin-treated US adults: the National Health and Nutrition Examination Survey","volume":"13","author":"Fan","year":"2019","journal-title":"Journal of Clinical Lipidology"},{"key":"2023010809165544000_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1158\/1055-9965.EPI-19-0206","article-title":"Insulin resistance in healthy U.S. adults: findings from the National Health and Nutrition Examination Survey (NHANES)","volume":"29","author":"Caporaso","year":"2020","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"2023010809165544000_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s11689-015-9113-x","article-title":"Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms","volume":"7","author":"Guna","year":"2015","journal-title":"Journal of Neurodevelopmental Disorders"},{"key":"2023010809165544000_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.0000108926.04022.0C","article-title":"Association of the metabolic syndrome with history of myocardial infarction and stroke in the third National Health and Nutrition Examination Survey","volume":"109","author":"Ninomiya","year":"2004","journal-title":"Circulation"},{"key":"2023010809165544000_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/eurheartj\/ehx659","article-title":"Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology\/European Atherosclerosis Society guidelines: a contemporary population-based study","volume":"39","author":"Madsen","year":"2018","journal-title":"European Heart Journal"},{"key":"2023010809165544000_bib38","first-page":"e002725","article-title":"Polygenic hyperlipidemias and coronary artery disease risk","volume":"13","author":"Ripatti","year":"2020","journal-title":"Circulation: Genomic and Precision Medicine"},{"key":"2023010809165544000_bib39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","article-title":"LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias","volume":"55","author":"Johansen","year":"2014","journal-title":"Journal of Lipid Research"},{"key":"2023010809165544000_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/cge.13832","article-title":"Development of a new expanded next-generation sequencing panel for genetic diseases involved in dyslipidemia","volume":"98","author":"Marmontel","year":"2020","journal-title":"Clinical Genetics"},{"key":"2023010809165544000_bib41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1192\/bjp.2018.258","article-title":"Low prevalence of substance use in people with 22q11.2 deletion syndrome","volume":"215","author":"Vingerhoets","year":"2019","journal-title":"British Journal of Psychiatry"},{"key":"2023010809165544000_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archinte.166.3.285","article-title":"Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials","volume":"166","author":"Nordmann","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"2023010809165544000_bib43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/clc.23104","article-title":"Aerobic exercise reduces triglycerides by targeting apolipoprotein C3 in patients with coronary heart disease","volume":"42","author":"Wang","year":"2019","journal-title":"Clinical Cardiology"},{"key":"2023010809165544000_bib44","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/0026-0495(82)90085-3","article-title":"Acute decrease in serum triglycerides with exercise: is there a threshold for an exercise effect?","volume":"31","author":"Cullinane","year":"1982","journal-title":"Metabolism: Clinical and Experimental"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/187\/1\/EJE-21-1104.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/187\/1\/91\/48515926\/eje-21-1104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/187\/1\/91\/48515926\/eje-21-1104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:17:32Z","timestamp":1676391452000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/187\/1\/91\/6972095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eje-21-1104","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7]]},"published":{"date-parts":[[2022,5,19]]}}}